Skip to content
Screener

ANI Pharmaceuticals ANIP Prepaid & Other Current

Prepaid & Other Current at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$112.01M+31.3%
Viatris logo
ViatrisVTRS
$2.11B+25.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$3.91M-26.2%
ALN
Alnylam PharmaceuticalsALNY
$302.18M+105%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$5.71M+127%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$4.94M+65.8%

Other financials

Income statement

See full
Revenue$266.0M+25.9%
Gross profit$165.9M+21.3%
Operating income$40.5M+191%
Net income$24.7M+189%
EPS (diluted)$1.05+192%

Balance sheet

See full
Cash & equivalents$360.2M+65.4%
Total debt$301.5M-4.2%
Total equity$597.2M+36.7%
Total assets$1.5B+11.3%

Cash flow

See full
Operating cash flow$56.7M-25.3%
CapEx$3.1M-23.9%
Free cash flow$53.6M-25.3%

Valuation

See full
Market cap$1.78B+0.8%
Enterprise value$1.72B-7.6%
P/E16.4×
P/S1.8×-0.5×

Profitability

See full
Gross margin60.4%-0.7pp
Operating margin15.4%
Net margin11.1%+10.0pp
FCF margin17.7%+0.9pp

Returns & leverage

See full
Return on equity21%+19.1pp
Debt / equity0.5×-0.2×
Current ratio2.9×+0.4×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 7:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001023024-26-000069
Line itemJune 30,2026December 31,2025
Restricted cash3536
Accounts receivable, net274,469281,082
Inventories143,149143,067
Prepaid expenses and other current assets31,94234,216
Investment in equity securities15,6269,131
Total Current Assets825,433753,117
Non-current Assets
Property and equipment, net73,22362,476

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is ANI Pharmaceuticals's prepaid & other current?
ANI Pharmaceuticals (ANIP) reported prepaid & other current of $31.94M in Q2 2026.
How has ANI Pharmaceuticals's prepaid & other current changed year-over-year?
ANI Pharmaceuticals's prepaid & other current increased by 111.4% year-over-year, from $15.11M to $31.94M.
What is the long-term trend for ANI Pharmaceuticals's prepaid & other current?
Over 5 years (2020 to 2025), ANI Pharmaceuticals's prepaid & other current has grown at a 42.3% compound annual growth rate (CAGR), from $5.86M to $34.22M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about ANI Pharmaceuticals's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude